Consolidated Statements of Shareholders’ Equity (Deficit) (USD $)	Exercise Agreement [Member] Additional Paid-in Capital [Member] USD ($)	Offer to Exercise [Member] Additional Paid-in Capital [Member] USD ($)	Preferred Stock [Member]	Common Stock [Member] USD ($)	Additional Paid-in Capital [Member] USD ($)	Retained Earnings [Member] USD ($)	Total USD ($)
Beginning balance at Dec. 31, 2011						$ (60,689,200)
Beginning balance at Dec. 31, 2011					61,398,600
Beginning balance at Dec. 31, 2011				8,200
Beginning balance (in Shares) at Dec. 31, 2011			0
Beginning balance (in Shares) at Dec. 31, 2011				81,886,926
Common stock - shares outstanding
Employee stock option issuances (in Shares)				615,447
Vesting of restricted stock awards (in Shares)				114,377
Common stock – amount
Exercise of employee stock options				100
Accumulated deficit
Net loss						(8,176,700)	(8,176,700)
Total Shareholders' Deficit						(6,432,200)	(6,432,200)
Stock-based compensation expense					739,700
Stock-based compensation expense – severance agreement					237,400
Proceeds from exercise of employee stock options					49,700
Ending balance at Dec. 31, 2012					62,425,400
Ending balance at Dec. 31, 2012						(68,865,900)	(68,865,900)
Ending balance at Dec. 31, 2012				8,300
Ending balance (in Shares) at Dec. 31, 2012			0				0
Ending balance (in Shares) at Dec. 31, 2012				82,616,750			82,616,750
Common stock - shares outstanding
Employee stock option issuances (in Shares)				2,464,332
Exercise of warrants (in Shares)				11,772,500			11,772,500
Vesting of restricted stock awards (in Shares)				1,657,040
Common stock – amount
Exercise of employee stock options				200
Exercise of warrants				1,300
Accumulated deficit
Net loss						(3,746,000)	(3,746,000)
Total Shareholders' Deficit						(904,800)	(904,800)
Stock-based compensation expense					834,900
Proceeds from exercise of employee stock options					433,600
Proceeds from exercise of warrants					2,969,300
Reclassification of warrants liability to equity from amendment of warrants					4,391,000
Reclassification of warrants liability to equity from exercise of warrants					602,500
Issuance of new warrants	514,800	45,600
New warrants recorded as cost of Offer to Exercise					(45,600)
New warrants recorded as cost of Exercise Agreement					(514,800)
Accretion of compensation expense – consultant warrants					40,600
Ending balance at Dec. 31, 2013					71,697,300
Ending balance at Dec. 31, 2013						(72,611,900)	(72,611,900)
Ending balance at Dec. 31, 2013				$ 9,800
Ending balance (in Shares) at Dec. 31, 2013			0				0
Ending balance (in Shares) at Dec. 31, 2013				98,510,622			98,510,622